Literature DB >> 2015968

Progressive deterioration of endocrine function after intraportal but not kidney subcapsular rat islet transplantation.

W F Hiller1, J Klempnauer, R Lück, B Steiniger.   

Abstract

In inbred streptozocin-induced diabetic rats, the long-term function of different endocrine pancreatic isografts was compared. Isolated islets transplanted into the portal vein showed a progressive deterioration of function over time. In contrast, islets under the kidney capsule sustained a constant long-term function controlling all clinical signs of diabetes. Recipients of kidney subcapsular islets displayed normal growth rate, peripheral serum glucose and insulin levels, and metabolic parameters. However, their functional reserve was markedly reduced as revealed by diminished glucose tolerance and reduced insulin-secreting capacity after an intravenous glucose challenge. Vascularized whole-organ pancreatic grafts with portal venous drainage led to complete normalization of all parameters determined in this study. This study showed that the long-term function of islets transplanted under the kidney capsule is superior compared with islets transplanted into the portal vein.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2015968     DOI: 10.2337/diab.40.1.134

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  15 in total

1.  Effect of donor islet mass on metabolic normalization in streptozotocin-diabetic rats.

Authors:  B Keymeulen; H Teng; M Vetri; F Gorus; P In't Veld; D G Pipeleers
Journal:  Diabetologia       Date:  1992-08       Impact factor: 10.122

Review 2.  Advancing islet transplantation: from engraftment to the immune response.

Authors:  R F Gibly; J G Graham; X Luo; W L Lowe; B J Hering; L D Shea
Journal:  Diabetologia       Date:  2011-08-10       Impact factor: 10.122

Review 3.  Optimising islet engraftment is critical for successful clinical islet transplantation.

Authors:  O Korsgren; T Lundgren; M Felldin; A Foss; B Isaksson; J Permert; N H Persson; E Rafael; M Rydén; K Salmela; A Tibell; G Tufveson; B Nilsson
Journal:  Diabetologia       Date:  2007-11-27       Impact factor: 10.122

Review 4.  Bioengineered sites for islet cell transplantation.

Authors:  Sophie Vériter; Pierre Gianello; Denis Dufrane
Journal:  Curr Diab Rep       Date:  2013-10       Impact factor: 4.810

5.  HLA sensitization in islet transplantation.

Authors:  Michael R Rickels; Jane Kearns; Eileen Markmann; Maral Palanjian; James F Markmann; Ali Naji; Malek Kamoun
Journal:  Clin Transpl       Date:  2006

6.  An isolated venous sac as a novel site for cell therapy in diabetes mellitus.

Authors:  Zurab Kakabadze; Koba Shanava; Camillo Ricordi; A M James Shapiro; Sanjeev Gupta; Ekaterine Berishvili
Journal:  Transplantation       Date:  2012-08-27       Impact factor: 4.939

Review 7.  Transplantation in diabetes: a cell biological problem.

Authors:  F Purrello; D Pipeleers
Journal:  J Endocrinol Invest       Date:  1995-04       Impact factor: 4.256

8.  Transplantation for type I diabetes: comparison of vascularized whole-organ pancreas with isolated pancreatic islets.

Authors:  Adam Frank; Shaoping Deng; Xiaolun Huang; Ergun Velidedeoglu; Yong-Suk Bae; Chengyang Liu; Peter Abt; Robert Stephenson; Muhammad Mohiuddin; Thav Thambipillai; Eileen Markmann; Maral Palanjian; Marty Sellers; Ali Naji; Clyde F Barker; James F Markmann
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

9.  Comparison of four pancreatic islet implantation sites.

Authors:  Hyoung-Il Kim; Jae Eun Yu; Chung-Gyu Park; Sang-Joon Kim
Journal:  J Korean Med Sci       Date:  2009-01-19       Impact factor: 2.153

10.  Beta cell mass and growth after syngeneic islet cell transplantation in normal and streptozocin diabetic C57BL/6 mice.

Authors:  E Montaña; S Bonner-Weir; G C Weir
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.